Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + DHAP in Relapsed/Refractory Hodgkin Lymphoma
NCT01453504Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Aug 2012
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Hodgkin lymphoma (HL), sponsored by University of Cologne. Started Aug 2012; status: completed.
02
Drugs
everolimus
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01453504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453504.